BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20552721)

  • 1. Endothelin-1 aggravates hepatic ischemia/reperfusion injury during obstructive cholestasis in bile duct ligated mice.
    Nagai H; Kato A; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Furukawa K; Nozawa S; Yoshitomi H; Mitsuhashi N; Takeuchi D; Suda K; Yoshioka I; Miyazaki M
    J Surg Res; 2010 Jul; 162(1):46-53. PubMed ID: 20552721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation.
    Gehrke N; Nagel M; Straub BK; Wörns MA; Schuchmann M; Galle PR; Schattenberg JM
    Am J Physiol Gastrointest Liver Physiol; 2018 Mar; 314(3):G319-G333. PubMed ID: 29191940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obstructive jaundice impairs hepatic sinusoidal endothelial cell function and renders liver susceptible to hepatic ischemia/reperfusion.
    Yoshidome H; Miyazaki M; Shimizu H; Ito H; Nakagawa K; Ambiru S; Nakajima N; Edwards MJ; Lentsch AB
    J Hepatol; 2000 Jul; 33(1):59-67. PubMed ID: 10905587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditional loss of geranylgeranyl diphosphate synthase alleviates acute obstructive cholestatic liver injury by regulating hepatic bile acid metabolism.
    Jia WJ; Tang QL; Jiang S; Sun SQ; Xue B; Qiu YD; Li CJ; Mao L
    FEBS J; 2020 Aug; 287(15):3328-3345. PubMed ID: 31905247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atorvastatin does not protect against ischemia-reperfusion damage in cholestatic rat livers.
    Wiggers JK; van Golen RF; Verheij J; Dekker AM; van Gulik TM; Heger M
    BMC Surg; 2017 Apr; 17(1):35. PubMed ID: 28399849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary drainage attenuates postischemic reperfusion injury in the cholestatic rat liver.
    Kloek JJ; Marsman HA; van Vliet AK; Gouma DJ; van Gulik TM
    Surgery; 2008 Jul; 144(1):22-31. PubMed ID: 18571581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholestasis protects the liver from ischaemic injury and post-ischaemic inflammation in the mouse.
    Georgiev P; Navarini AA; Eloranta JJ; Lang KS; Kullak-Ublick GA; Nocito A; Dahm F; Jochum W; Graf R; Clavien PA
    Gut; 2007 Jan; 56(1):121-8. PubMed ID: 16763052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol attenuates cholestatic liver injury and its complications in common bile duct ligated rats.
    Abdel Kawy HS
    Eur J Pharmacol; 2015 Apr; 752():8-17. PubMed ID: 25666386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary intervention aggravates cholestatic liver injury, and induces hepatic inflammation, proliferation and fibrogenesis in BDL mice.
    Wen YA; Liu D; Zhou QY; Huang SF; Luo P; Xiang Y; Sun S; Luo D; Dong YF; Zhang LP
    Exp Toxicol Pathol; 2011 Mar; 63(3):277-84. PubMed ID: 20149605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholestasis is associated with hepatic microvascular dysfunction and aberrant energy metabolism before and during ischemia-reperfusion.
    Kloek JJ; Maréchal X; Roelofsen J; Houtkooper RH; van Kuilenburg AB; Kulik W; Bezemer R; Nevière R; van Gulik TM; Heger M
    Antioxid Redox Signal; 2012 Oct; 17(8):1109-23. PubMed ID: 22482833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Grape seed protects cholestatic rats liver from ischemia/reperfusion injury.
    Çakır T; Aslaner A; Tekeli SÖ; Güneş K; Kinaci E; Doğan U; Tekeli F; Akyüz C; Koç S; Yılmaz N
    Acta Cir Bras; 2016 Mar; 31(3):183-9. PubMed ID: 27050789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclopamine attenuates acute warm ischemia reperfusion injury in cholestatic rat liver: hope for marginal livers.
    Pratap A; Panakanti R; Yang N; Lakshmi R; Modanlou KA; Eason JD; Mahato RI
    Mol Pharm; 2011 Jun; 8(3):958-68. PubMed ID: 21491930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho inhibitor prevents ischemia-reperfusion injury in rat steatotic liver.
    Kuroda S; Tashiro H; Igarashi Y; Tanimoto Y; Nambu J; Oshita A; Kobayashi T; Amano H; Tanaka Y; Ohdan H
    J Hepatol; 2012 Jan; 56(1):146-52. PubMed ID: 21756846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice.
    Isayama F; Hines IN; Kremer M; Milton RJ; Byrd CL; Perry AW; McKim SE; Parsons C; Rippe RA; Wheeler MD
    Am J Physiol Gastrointest Liver Physiol; 2006 Jun; 290(6):G1318-28. PubMed ID: 16439470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammasome Is Activated in the Liver of Cholestatic Patients and Aggravates Hepatic Injury in Bile Duct-Ligated Mouse.
    Cai SY; Ge M; Mennone A; Hoque R; Ouyang X; Boyer JL
    Cell Mol Gastroenterol Hepatol; 2020; 9(4):679-688. PubMed ID: 31887435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice.
    Takeuchi D; Yoshidome H; Kato A; Ito H; Kimura F; Shimizu H; Ohtsuka M; Morita Y; Miyazaki M
    Hepatology; 2004 Mar; 39(3):699-710. PubMed ID: 14999688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
    Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
    Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rho-kinase inhibitor attenuates cholestasis-induced CXC chemokine formation, leukocyte recruitment, and hepatocellular damage in the liver.
    Laschke MW; Dold S; Jeppsson B; Schilling MK; Menger MD; Thorlacius H
    J Surg Res; 2010 Apr; 159(2):666-73. PubMed ID: 19159908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sortilin Deficiency Reduces Ductular Reaction, Hepatocyte Apoptosis, and Liver Fibrosis in Cholestatic-Induced Liver Injury.
    Hubel E; Saroha A; Park WJ; Pewzner-Jung Y; Lavoie EG; Futerman AH; Bruck R; Fishman S; Dranoff JA; Shibolet O; Zvibel I
    Am J Pathol; 2017 Jan; 187(1):122-133. PubMed ID: 27842214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Toll-like receptor 4 ameliorates experimental postischemic injury in the cholestatic liver through inhibition of high-mobility group box protein b1 (HMGB1) signaling.
    Yokoi T; Yokoyama Y; Kokuryo T; Yamaguchi J; Nagino M
    Surgery; 2018 Feb; 163(2):270-276. PubMed ID: 29191677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.